3-Chloroperbenzoic acid
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- m-cpba, intermediate cas no.937-14-4
- Category
- Pharmaceutical Intermediates
Apply a video call to the Supplier
Liaoning Kanion Huawe Pharmaceutical Co.,Ltd.
China
- Verified Certificate
-
6
| Product name | 3-Chloroperbenzoic acid | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | m-cpba , intermediate cas no.937-14-4 | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
Product Name：3-Chloroperbenzoic acid
MF：C7H5CLO3
MW：172.57
CAS：937-14-4
Standard：Enterprise Standard
Melting Point：92-94℃ (dec.)
Assat：75～77%；80～85%；85～93%
Package： 25KG/drum
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Mr.Guo Qingming
- Address
- No.65, Xianghuai Road,Shiqiaozi,Benxi,Liaoning
- Product Category
- Gastrointestinal Agents
- Year Established
- 2008
- No. of Total Employees
- 51-100
- Company introduction
-
Liaoning Kanion Huawe Pharmaceutical Co., Ltd is a joint venture company by Jiangsu Kanion Huawe Pharmaceutical Co., Ltd. and Liaoning Tengfei Pharmaceutical Co., Ltd. And is a manufacturer of API and intermediate, combining R&D, Production with Trade. Our company is located in the Chinese Medicine Capital - No.65,Xianghuai Road, Shiqiaozi,Benxi,Liaoning.Our company covers an area of over 20,000 square meters, with a construction area of over 14,000 square meters, and has a production line of 20 tons of PPI capacity for the production of the chemical active pharmaceutical ingredient, and our company passed the GMP verification. The main products are Lansoprazole, Pantoprazole Sodium and Rebeprazole Sodium and other pharmaceutical raw material and intermediates.
- Main Product
